447 Differences in Demographics and Treatment Outcome of Chronic Hepatitis C (CHC) Patients of Different European Origin Treated with Peginterferon ALFA-2A (40KDA) and Ribavirin (Peg/RBV) (original) (raw)

Depressive Episode Incidence in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin

Izabella Corsino

Arquivos de Gastroenterologia, 2016

View PDFchevron_right

No increase in depression with low-dose maintenance peginterferon in prior non-responders with chronic hepatitis C

Ziad Kronfol

Journal of Affective Disorders, 2011

View PDFchevron_right

Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C

Gunnar Norkrans

Hepatology, 2010

View PDFchevron_right

De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C

Felipe Andres Barria Garcia

Alimentary Pharmacology & Therapeutics, 2007

View PDFchevron_right

Early prediction of major depression in chronic hepatitis C patients during peg-interferon α-2b treatment by assessment of vegetative-depressive symptoms after four weeks

F. Nevens

World Journal of Gastroenterology, 2007

View PDFchevron_right

Frequency of depression and somatic symptoms in patients on interferon alpha/ribavirin for chronic hepatitis C

Tafazzul-E-Haque Mahmud

Journal of Ayub Medical College, Abbottabad: JAMC

View PDFchevron_right

Quality of life, depression, and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy

Katia Falasca

Clinical and investigative medicine. Médecine clinique et experimentale, 2009

View PDFchevron_right

The Effect of Combination Antiviral Therapy in the Treatment of Hepatitis C on the Occurrence of Depressive Disorder in Patients Treated for Hepatitis C in the Republic of Srpska

Visnja Banjac

Medical Archives

View PDFchevron_right

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals

Elfi Egmond

Revista Brasileira de Psiquiatria, 2019

View PDFchevron_right

Frequency of depression in chronic Hepatitis C naïve patients INTRODUCTION

Memon S Ali

View PDFchevron_right

Frequency of Depression in Chronic Hepatitis C naive patients

Abdul Memon

Pakistan Journal of Medical Sciences Online, 2011

View PDFchevron_right

ORIGINAL ARTICLES Depression within Hepatitis C virus patients: A case control study

amal abd

2019

View PDFchevron_right

Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C

Ziad Kronfol

2008

View PDFchevron_right

Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C

Antonio Russo

Gastroenterology, 2010

View PDFchevron_right

Depression in patients with chronic hepatitis C treated with interferon (IFN) — alpha therapy

Dominik Maria Rosenauer

European Neuropsychopharmacology, 2001

View PDFchevron_right

Outcomes of Peginterferon alfa-2a and Ribavirin Combination Therapy in a Resident-Initiated, Multidisciplinary, Hepatitis C Clinic

K. Nadeem Ahmed

2007

View PDFchevron_right

Multimethod assessment of baseline depression and relationship to hepatitis C treatment discontinuation

Sarah Prieto

The International Journal of Psychiatry in Medicine, 2018

View PDFchevron_right

Depressive symptoms and viral clearance in patients receiving interferon-α and ribavirin for hepatitis C

Andrew Miller

Brain, Behavior, and Immunity, 2005

View PDFchevron_right

Interferon-Induced Depression in Chronic Hepatitis C

Manuel Valdés

The Journal of Clinical Psychiatry, 2012

View PDFchevron_right

Depressive symptoms and viral clearance in patients receiving interferon-? and ribavirin for hepatitis C

Sherry Broadwell

Brain Behav Immun, 2005

View PDFchevron_right

Depression and pegylated interferon-based hepatitis C treatment

Murali Rao

International Journal of Interferon, Cytokine and Mediator Research, 2012

View PDFchevron_right

Predictors of Psychopathological Outcome During Peg-Interferon and Ribavirin Therapy in Patients with Chronic HCV-Correlated Hepatitis

Gian Luigi Prati

Journal of Interferon & Cytokine Research, 2013

View PDFchevron_right

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

Wan-long Chuang

Gut, 2007

View PDFchevron_right

The effect of direct antiviral treatment on the depression, anxiety, fatigue and quality-of-life in chronic hepatitis C patients

SEBATİ ÖZDEMİR

European Journal of Gastroenterology & Hepatology, 2019

View PDFchevron_right

Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: A Danish nationwide cohort study

Henrik Krarup

BMC Infectious Diseases, 2011

View PDFchevron_right

Treatment Response of Chronic Hepatitis C Patients and Health-Related Quality of Life

Nessrin El-Nimr

Journal of High Institute of Public Health, 2016

View PDFchevron_right

Haematological abnormalities and quality of life in patients with chronic hepatitis C who meet major depression disorder during antiviral therapy

Salvatore Calò

2010

View PDFchevron_right